Complement-mediated inhibition of immune precipitation in patients with immune complex diseases.
The ability of human sera to prevent the precipitation of antigen-antibody complexes has been investigated. The early complement components including C3 are required for optimal prevention of immune precipitation, whereas the later components are not required. The sera of 36 of 75 patients with seropositive rheumatoid arthritis (RA), 14 of 32 with SLE and four of 17 with glomerulonephritis exhibited reduced capacities to prevent immune precipitation. In contrast sera from patients with seronegative RA, ankylosing spondylitis, psoriatic arthritis or degenerative joint disease were normal in this respect. In SLE and GN sera hypocomplementaemia was frequently associated but not always with failure to prevent immune precipitation, whereas only a small proportion of the patients with seropositive RA and reduced capacity to retain complexes in a soluble form were hypocomplementaemic. Thus the failure of sera to prevent the precipitation of antigen-antibody complexes is not always associated with hypocomplementaemia.
D000936:Antigen-Antibody Complex / Q000378:metabolism*; D001168:Arthritis / Q000276:immunology; D001172:Arthritis, Rheumatoid / Q000276:immunology; D011232:Chemical Precipitation; D003165:Complement System Proteins / Q000172:deficiency / Q000502:physiology*; D005260:Female; D005921:Glomerulonephritis / Q000276:immunology; D006801:Humans; D007105:Immune Complex Diseases / Q000276:immunology*; D007700:Kinetics; D008180:Lupus Erythematosus, Systemic / Q000276:immunology; D008297:Male
D000936:Antigen-Antibody Complex; D003165:Complement System Proteins